YD Bio (YDESW) Total Non-Current Liabilities (2024 - 2026)

YD Bio (YDESW) has reported Total Non-Current Liabilities for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.6 million, down 99.4% from the prior year.
• Total Non-Current Liabilities was $1.1 million for Q2 2026 at YD Bio, down from $1.6 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $274.0 million in Q4 2024 and troughed at $1.1 million in Q2 2026.
• A 3-year average of $92.2 million and a median of $1.6 million in 2025 frame the typical range for Total Non-Current Liabilities.
• The widest YoY moves for Total Non-Current Liabilities: up 99.4% in 2025, down 99.4% in 2025.
• Over 3 years, Total Non-Current Liabilities stood at $274.0 million in 2024, then sank by 99.4% to $1.6 million in 2025, then sank by 34.97% to $1.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $1.1 million (Q2 2026), $1.6 million (Q4 2025), and $274.0 million (Q4 2024), per Business Quant data.